BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 20948440)

  • 1. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
    Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
    J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
    Lin Q; Song Y; Zhu X; Yang S; Zheng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.
    Manousou P; Kolios G; Drygiannakis I; Koulentaki M; Pyrovolaki K; Voumvouraki A; Notas G; Bourikas L; Papadaki HA; Kouroumalis E
    Clin Exp Immunol; 2013 Apr; 172(1):9-15. PubMed ID: 23480180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease.
    Marshall A; Celentano A; Cirillo N; McCullough M; Porter S
    PLoS One; 2017; 12(3):e0172821. PubMed ID: 28253295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N
    Front Immunol; 2020; 11():976. PubMed ID: 32547545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
    Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
    Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O
    J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.
    Bronger H; Kraeft S; Schwarz-Boeger U; Cerny C; Stöckel A; Avril S; Kiechle M; Schmitt M
    Breast Cancer Res; 2012 Feb; 14(1):R30. PubMed ID: 22333315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
    Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
    J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
    Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
    Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
    Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
    Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye.
    Coursey TG; Bohat R; Barbosa FL; Pflugfelder SC; de Paiva CS
    J Immunol; 2014 Nov; 193(10):5264-72. PubMed ID: 25288568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M; Carter S; Hofer MJ; Campbell IL
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells].
    Song Y; Lin Q; Zheng J; Zhu X; Yang S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):673-6. PubMed ID: 25001926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.
    Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G
    J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
    Mauldin IS; Wages NA; Stowman AM; Wang E; Smolkin ME; Olson WC; Deacon DH; Smith KT; Galeassi NV; Chianese-Bullock KA; Dengel LT; Marincola FM; Petroni GR; Mullins DW; Slingluff CL
    Cancer Immunol Immunother; 2016 Oct; 65(10):1189-99. PubMed ID: 27522581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.
    Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC; Reinhart TA
    J Med Primatol; 2003 Aug; 32(4-5):247-64. PubMed ID: 14498985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.